Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Infection|August 1, 2006
Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patientsIsabelle Malet, Bénédicte Roquebert, Cécile Dalban, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2009
Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasmaCathia Soulié, Roland Tubiana, Anne Simon, et al.
Journal of Medical Virology|March 25, 2008
Structural effects of amino acid variations between B and CRF02-AG HIV-1 integrasesIsabelle Malet, Cathia Soulie, Luba Tchertanov, et al.
The Journal of Antimicrobial Chemotherapy|September 4, 2008
Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 proteaseSidonie Lambert-Niclot, Philippe Flandre, Isabelle Malet, et al.
The Journal of Antimicrobial Chemotherapy|February 18, 2009
Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patientsIsabelle Malet, Olivier Delelis, Cathia Soulie, et al.
AIDS (London, England)|June 15, 2012
E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposureSlim Fourati, Isabelle Malet, Sidonie Lambert, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2009
Impact of Y143 HIV-1 integrase mutations on resistance to raltegravir in vitro and in vivoOlivier Delelis, Sylvain Thierry, Frédéric Subra, et al.
Scientific Reports|September 1, 2021
Seroprevalence and molecular diversity of Human Herpesvirus 8 among people living with HIV in Brazzaville, CongoGervillien Arnold Malonga, Aude Jary, Valentin Leducq, et al.
The Journal of Antimicrobial Chemotherapy|April 9, 2011
Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patientsIsabelle Malet, Marc Wirden, Slim Fourati, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2013
A single amino-acid change in a highly conserved motif of gp41 elicits HIV-1 neutralization and protects against CD4 depletionCaroline Petitdemange, Abla Achour, Stefania Dispinseri, et al.
Pageof 6